A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey.
Citation: Unpublished 2017/10/03Department: Medicine/Nuclear MedicineForm of publication: Poster PresentationYear: 2017Conference information: MedStar Health Research Institute: MedStar Health Research Symposium, North Bethesda, MD., Fiscal year: FY2018Local accession number: A2017_050Date added to catalog: 2018-08-01Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Poster Presentation | MedStar Authors Catalog | Poster | Available |